Literature DB >> 12843177

Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution.

Lidija Jovanovic1, Brett Delahunt, Bryan McIver, Norman L Eberhardt, Stefan K G Grebe.   

Abstract

It is widely assumed thyroid carcinomas, adenomas, and many hyperplastic nodules are monoclonal. This belief is based on X-chromosome inactivation analyses of thyroid tumors. However, X-chromosome inactivation studies of tumors are informative only when interpreted in the context of the clonal composition of the surrounding normal tissue, and in the case of thyroid tissue, such analyses have never been systematically performed in humans. The aim of this study was to determine the embryonal patch size of the human thyroid gland. We performed human androgen receptor (HUMARA) assay-based X-chromosome inactivation analysis on 20 microdissected normal thyroid specimens from 16 female subjects. Monoclonality was observed in 70% of tested specimens, and polyclonal X-inactivation patterns were present in only 30% of specimens. According to our results the monoclonal patch size of normal human thyroid tissue is between 48 mm(2) and 128 mm(2) (1-4 x 10(5) thyrocytes). Our data indicate that normal thyroid epithelium is organized into large stem cell-derived monoclonal patches. Therefore, monoclonality in neoplastic and hyperplastic lesions may just be a reflection of normal thyroid epithelium clonal composition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843177     DOI: 10.1210/jc.2002-021552

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

Review 2.  Passenger mutations as a marker of clonal cell lineages in emerging neoplasia.

Authors:  Jesse J Salk; Marshall S Horwitz
Journal:  Semin Cancer Biol       Date:  2010-10-15       Impact factor: 15.707

Review 3.  Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Authors:  Zubair W Baloch; Sylvia L Asa; Justine A Barletta; Ronald A Ghossein; C Christofer Juhlin; Chan Kwon Jung; Virginia A LiVolsi; Mauro G Papotti; Manuel Sobrinho-Simões; Giovanni Tallini; Ozgur Mete
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 3.943

4.  Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development.

Authors:  Elin Schoultz; Ellen Johansson; Carmen Moccia; Iva Jakubikova; Naveen Ravi; Shawn Liang; Therese Carlsson; Mikael Montelius; Konrad Patyra; Jukka Kero; Kajsa Paulsson; Henrik Fagman; Martin O Bergo; Mikael Nilsson
Journal:  Dis Model Mech       Date:  2021-08-11       Impact factor: 5.758

5.  Scintigraphic detection of dual ectopic thyroid tissue: experience of a Chinese tertiary hospital.

Authors:  Zhaowei Meng; Shanshan Lou; Jian Tan; Qiang Jia; Rongxiu Zheng; Geli Liu; Mei Zhu; Qing He; Dong Li
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.